Literature DB >> 13863061

Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 3.

P ATANASIU, D A CANNON, D J DEAN, J P FOX, K HABEL, M M KAPLAN, R E KISSLING, H KOPROWSKI, P LEPINE, F PEREZ GALLARDO.   

Abstract

This study is the third in a series on virus-neutralizing antibody response to different schedules of antirabies serum and vaccines in previously non-exposed persons. Three types of vaccine were studied-phenolized (Semple), duck embryo and high-egg-passage (HEP) chicken embryo. Reduced schedules of vaccine, consisting of 2-7 inoculations given at various intervals, did not give results comparable in efficacy (time of appearance, level and persistence of antibody) with schedules comprising at least 14 daily inoculations of vaccine as determined in previous trials. The effectiveness of a booster dose in previously sensitized individuals was confirmed with a demonstration that a rise in serum antibody appears between 4 and 8 days after the booster inoculation. Effective sensitization appears to be as much a function of spacing of inoculations as of total dosage of vaccine antigen. Interference by immune serum with the antigenicity of subsequently administered vaccine, noted previously by the present authors and by other workers, was again confirmed. This interference could be overcome by the administration of a sufficient amount of vaccine.

Entities:  

Keywords:  RABIES/immunology

Mesh:

Substances:

Year:  1961        PMID: 13863061      PMCID: PMC2555550     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs.

Authors:  F B PECK; H M POWELL; C G CULBERTSON
Journal:  J Lab Clin Med       Date:  1955-05

2.  Vaccination against rabies with duck-embryo and Semple vaccines.

Authors:  M GREENBERG; J CHILDRESS
Journal:  J Am Med Assoc       Date:  1960-05-28

3.  Primary antirabies immunization of man with HEP flury virus vaccine.

Authors:  J M RUEGSEGGER; J BLACK; G R SHARPLESS
Journal:  Am J Public Health Nations Health       Date:  1961-05

4.  Avian embryo rabies immunization I. Duck-embryo vaccine administered intradermally in man.

Authors:  G R ANDERSON; P R SCHNURRENBERGER; R A MASTERSON; F H WENTWORTH
Journal:  Am J Hyg       Date:  1960-03

5.  [The use of antirabies gamma globulin in subjects severely bitten by rabid wolves or other animals].

Authors:  M SELIMOV; L BOLTUCIJ; E SEMENOVA; G KOBRINSKIJ; L ZMUSKO
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1959

6.  Antiserum in the prophylaxis of rabies.

Authors:  K HABEL
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

7.  [Field trials with rabies vaccine on persons bitten by rabid wolves].

Authors:  M BALTAZARD; M BAHMANYAR
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

8.  Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf.

Authors:  K HABEL; H KOPROWSKI
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

9.  Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).

Authors:  C G CULBERTSON; F B PECK; H M POWELL
Journal:  J Am Med Assoc       Date:  1956-12-08

10.  Study of antirabies immunization of man; observations with HEP Flury and other vaccines, with and without hyperimmune serum, in primary and recall immunizations.

Authors:  J P FOX; H KOPROWSKI; D P CONWELL; J BLACK; H M GELFAND
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

View more
  9 in total

1.  An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.

Authors:  G M Baer; S A Moore; J H Shaddock; H B Levy
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  INFECTION OF THE ONE-DAY OLD FERTILE HEN'S EGG WITH RABIES VIRUS. VIII. BETA-PROPIOLACTONE INACTIVATED VACCINE PRODUCED BY INOCULATION OF ONE-DAY EGGS WITH NISHIGAHARA-O30-M (NOPM) STRAIN.

Authors:  K YOSHINO; K SAITO
Journal:  Arch Gesamte Virusforsch       Date:  1963-08-26

3.  [On the problem of central nervous complications following rabies vaccination].

Authors:  K JELLINGER; F SEITELBERGER
Journal:  Dtsch Z Nervenheilkd       Date:  1963

Review 4.  Rabies. Suggested indications for treatment of exposed persons.

Authors:  G L Humphrey
Journal:  Calif Med       Date:  1967-11

5.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4.

Authors:  P Atanasiu; D J Dean; K Habel; M M Kaplan; H Koprowski; P Lépine; C Serié
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

Review 6.  The vaccination of man and other animals against rabies.

Authors:  J Crick
Journal:  Postgrad Med J       Date:  1973-08       Impact factor: 2.401

7.  Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects.

Authors:  V J Cabasso; J C Loofbourow; R E Roby; W Anuskiewicz
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine.

Authors:  B G Archer; R E Dierks
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

9.  Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.

Authors:  Paola De Benedictis; Andrea Minola; Elena Rota Nodari; Roberta Aiello; Barbara Zecchin; Angela Salomoni; Mathilde Foglierini; Gloria Agatic; Fabrizia Vanzetta; Rachel Lavenir; Anthony Lepelletier; Emma Bentley; Robin Weiss; Giovanni Cattoli; Ilaria Capua; Federica Sallusto; Edward Wright; Antonio Lanzavecchia; Hervé Bourhy; Davide Corti
Journal:  EMBO Mol Med       Date:  2016-04-01       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.